Watchlist Price Alert

Ascentage Pharma Group In... (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

31.98

-0.15 (-0.47%)

At close: Jun 17, 2025, 10:40 AM

Ascentage Pharma International Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.24B	1.07B	1.48B	1.71B	1.02B	878.51M	957.09M	14.82M	294.53M
Short-Term Investments	47.06M	4.41M	18.7M	n/a	n/a	n/a	14.4M	384.17M	157.39M
Long-Term Investments	33.86M	18.95M	18.53M	4.37M	4.86M	4.62M	n/a	n/a	1.91M
Other Long-Term Assets	59M	10.05M	361.93M	63.73M	82.03M	56.72M	71.94M	36.22M	13.31M
Receivables	99.07M	163.54M	61.49M	54.13M	480K	2.53M	5.25M	7.85M	8.31M
Inventory	6.6M	16.17M	9.45M	616.63K	n/a	n/a	n/a	n/a	n/a
Other Current Assets	24.63M	24.54M	16.6M	59.26M	17.31M	3.95M	6.42M	25.18K	11.22K
Total Current Assets	1.47B	1.34B	1.64B	295.81M	1.08B	909.11M	990.22M	414.71M	463.7M
Property-Plant & Equipment	905.86M	957.23M	650.02M	854.3M	73.22M	110.22M	33.99M	25.33M	4.51M
Goodwill & Intangibles	100.69M	110.14M	109M	85.11M	122.09M	129M	133.22M	105.4M	111.82M
Total Long-Term Assets	1.14B	1.16B	1.19B	1.05B	99.7M	295.94M	239.16M	166.95M	129.64M
Total Assets	2.62B	2.5B	2.83B	2.94B	1.73B	1.21B	1.23B	581.66M	593.34M
Account Payables	91.97M	72.44M	95.56M	70.86M	23.36M	13.08M	5.08M	3.82M	156K
Deferred Revenue	54.09M	38.41M	3.5M	n/a	6.58K	6.6K	6.55K	6.6K	121.02K
Short-Term Debt	769.62M	606.65M	74.57M	39.8M	44.75M	85M	35M	n/a	n/a
Other Current Liabilities	22.87M	19.42M	2.82M	58.73M	16.88M	8.47M	24.76M	12.23M	12.46M
Total Current Liabilities	1.17B	934.17M	126.75M	361.11M	276.15M	202.06M	105.27M	79.53M	77.62M
Long-Term Debt	868.64M	1.17B	1.27B	1.03B	473.06M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.27M	18.3M	35.33M	52.34M	73.57M	51.25M	2.09B	594.93M	499.36M
Total Long-Term Liabilities	1.18B	1.5B	1.54B	1.34B	608.27M	112.51M	2.14B	633.93M	530.33M
Total Liabilities	2.34B	2.43B	2.42B	1.71B	884.42M	314.57M	2.24B	713.46M	607.95M
Total Debt	1.67B	1.8B	1.79B	1.08B	529.7M	101.41M	42.04M	4.9M	830K
Common Stock	214K	197K	180K	178K	154K	142K	9.18K	n/a	n/a
Retained Earnings	-5.77B	-5.37B	-4.44B	-3.56B	-2.77B	-2.1B	-615.82M	n/a	n/a
Comprehensive Income	-510.59M	-504.46M	-518.51M	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	264.19M	60.42M	408.66M	1.23B	846.62M	890.48M	-1.01B	-131.8M	-14.61M
Total Investments	33.86M	18.95M	18.53M	27.84M	31.77M	32.19M	59.52M	30.33M	12.55M